-
The "barrier-free" mode of mergers and acquisitions is here, and new openings and cancellations are handled simultaneously
Time of Update: 2021-12-03
Through reorganizing the licensing procedures and re-optimizing the licensing procedures, the "three-step approach" has changed the old model of closing and reopening stores in the past, opening up a new "barrier-free" model of simultaneous cancellation of new offices, and realizing the merger and reorganization of pharmaceutical retail chain enterprises Seamless docking of non-stop operation in China .
-
The Yangtze River Delta Alliance is here!
Time of Update: 2021-12-03
According to the documents circulating this time, the alliance will start from the expiration of the national procurement and selection drug agreement as the entry point, and follow the path of "drugs first, then consumables" to advance the joint action of drug price recruitment and procurement in the Yangtze River Delta step by step .
-
The "Basic Medical Insurance and Medical Consumables Catalog" is dynamically adjusted!
Time of Update: 2021-12-03
On November 19, the National Medical Insurance Administration issued an announcement for public comments on the "Interim Measures for the Management of Payment of Medical Consumables for Basic Medica
-
The future of the 100 billion yuan dental implant market can be expected
Time of Update: 2021-12-03
It is foreseeable that whether it is included in centralized procurement or medical insurance, the accessibility of dental implants in China will be improved, the market demand will be greatly released, and the industry will usher in new development opportunities .
-
Starting from innovative payment, moving towards comprehensive patient service
Time of Update: 2021-12-03
At the same time, relying on the innovative payment and patient welfare platform of Meixin Health-Yaokangfu, the two parties will jointly explore to provide exclusive rights and services for patients who use Xeroxhui products to standardize treatment, so that more patients can enjoy More advanced, safe, and portable medical services can improve treatment results and improve the quality of life .
-
Hit the 40 billion market!
Time of Update: 2021-11-13
A few days ago, Henan Tianfang Pharmaceutical Traditional Chinese Medicine/Shenzhen Shasong Lesheng received the CDE acceptance for the marketing application of Naoshang Lesheng Granules submitted in the new drug category 1.
Henan Tianfang Pharmaceutical TCM once submitted a listing application for Naoshang Lesheng Granules (new drug category 6.
-
Digestive system Chinese patent medicine Jiangzhong and Tai Chi lead retail TOP20 rankings change
Time of Update: 2021-11-13
The latest data from Mi Nei. com shows that Chinese urban entities in recent years The market for proprietary Chinese medicines in the terminal digestive system of pharmacies has maintained steady growth, with sales exceeding 14 billion yuan in 2020, and is expected to reach a new high in 2021, a year-on-year increase of 3.
-
Increased by 9.77%! Terminal drug sales of public medical institutions in China are 617.4 billion yuan
Time of Update: 2021-11-13
Under the combined effect of opportunities and challenges, the sales of terminal drugs in China's public medical institutions achieved a recovery growth in the first half of 2021, an increase of 9.
-
State Food and Drug Administration: Increase penalties for unqualified cosmetics producers and operators in accordance with the law
Time of Update: 2021-11-13
According to the official website of the State Food and Drug Administration, in order to investigate and punish the illegal activities found in the national cosmetics supervision and sampling inspect
-
"CCTV News" Is it really possible to return a 5,000 principal to 400,000 yuan? "Science knowledge"
Time of Update: 2021-11-13
Is it really possible to return the blood of 400,000 to 5,000 principals?
[Teacher Hua Q6549_724] Take you off [zhgcw 8 8 diancom] [Inviting love: 5219-8888]╇Credit platform╇╇The strongest tutor╇【Strength belt Human landing mentor team╇▊Reality.
Strength.
Credit.
-
"CCTV News" QQ "Baidu Know" of 2021 Rebirth Planner
Time of Update: 2021-11-13
2021 Rebirth Planner’s QQ╇[Teacher Hua Q6549_724] takes you off [zhgcw 8 8 diancom] [Invitation: 5219-8888]╇Credit platform╇╇The strongest mentor╇[Strength to bring people to shore mentor team╇ ▊ Rea
-
Yunnan Baiyao stocks suffered a huge loss of 1.5 billion, and the net profit of Northeast Pharmaceutical and Taiji Group increased by more than 1000%!
Time of Update: 2021-11-13
Judging from the disclosed financial data, in the third quarter of 2021, Taiji Group's net profit attributable to shareholders of listed companies after deducting non-recurring gains and losses was 9,712,600 yuan, a year-on-year increase of only 127.
-
Report: The rapid development of China's pharmaceutical innovation and the original innovation ability needs to be strengthened
Time of Update: 2021-11-13
According to the report, the number of China's innovative drugs approved for marketing in 2020 will be 9 times that of 2016, and the simultaneous R&D, registration and review of domestic and foreign drugs has been gradually realized .
-
『CCTV News』Quick three big and small single and double blood return skills "Baidu experience"
Time of Update: 2021-11-13
Quick three size single and double blood return skills╇ [Teacher Hua Q6549_724] take you off [zhgcw 8 8 dian com] [Inviting love: 5219-8888] ╇ reputation platform╇╇ the strongest tutor╇[Strength to b
-
The domestic PD-1 annual fee may fall below 30,000? Where is the way out for sky-high drugs? 2021 Medical Insurance Negotiation Outlook
Time of Update: 2021-11-13
In the field of small molecule kinase inhibitors, Soochow Securities predicts that the price reduction of Iris Vometinib may reach 75% this time, and the annual treatment fee will be reduced from 417,000 yuan to about 100,000 yuan .
-
115 supplementary drugs will be transferred out of Shandong Medical Insurance
Time of Update: 2021-11-13
On July 14, the Jiangsu Provincial Medical Insurance Bureau and the Jiangsu Provincial Department of Human Resources and Social Security issued the "Regarding the Publication of the List of Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drugs" "Notice of the List" announced the second batch of digested lists of supplementary drugs in 156 provinces .
-
How much can the price of a pacemaker be reduced by the 22 provincial Super Purchasing Group?
Time of Update: 2021-11-13
The dual-chamber pacemaker is the main application type in the domestic market, and the price is about 50,000 yuan .
On the other hand, the price of China's mainstream dual-chamber pacemaker is around 50,000 yuan, which is mainly imported, which also causes a heavy economic burden .
-
Jishui New Tea) Wuhan sz and sn center [Mobile Sohu]
Time of Update: 2021-11-13
Musk said, "Recently, many people think that unrealized gains are a tax avoidance method, so I suggest selling 10% of Tesla stock .
Do you support this proposal?" Musk also said that regardless of the outcome, it will Observe the results of this voting .
-
"CCTV News" A mentor who is truly capable of bringing back blood and success, "Baidu Knows"
Time of Update: 2021-11-13
A mentor who is truly capable of bringing back blood and success╇[Teacher Hua Q6549_724] Takes you off [zhgcw 8 8 diancom] [Invitation: 5219-8888] ╇Credit platform╇╇The strongest mentor╇[Strength to bring people ashore Mentor Team╇ ▊ Reality.
Strength.
-
China Non-prescription Drug Association released the "2021 China Non-prescription Drug Products Comprehensive Statistical Ranking (Chemical Drugs)"
Time of Update: 2021-11-13
The China Non-Prescription Drug Association released the "2021 China Non-Prescription Drug Product Comprehensive Statistical Ranking (Chemical Medicine)" .
Since 2006, the China Non-prescription Drug Association has carried out statistical research on non-prescription drug companies and product brands every year, and has received positive responses from the industry.
